Premium
A case of group II non‐specific interstitial pneumonia developed during corticosteroid therapy after acute respiratory distress syndrome
Author(s) -
Ishioka Shinichi,
Nishisaka Takashi,
Maeda Akihiro,
Hiyama Keiko,
Yamakido Michio
Publication year - 1999
Publication title -
respirology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.857
H-Index - 85
eISSN - 1440-1843
pISSN - 1323-7799
DOI - 10.1046/j.1440-1843.1999.00191.x
Subject(s) - medicine , ards , acute respiratory distress , corticosteroid , diffuse alveolar damage , pneumonia , interstitial lung disease , respiratory distress , idiopathic interstitial pneumonia , pulmonary fibrosis , fibrosis , idiopathic pulmonary fibrosis , gastroenterology , interstitial pneumonia , lung , surgery
Non‐specific interstitial pneumonia/fibrosis (NSIP) is a relatively new entity among idiopathic interstitial pneumonias. This disease is pathologically characterized by varying proportions of interstitial inflammation and fibrosis that appear to occur over a single, short period of time, and is clinically characterized by a generally good prognosis. Although corticosteroid therapy is widely considered to be effective for treatment of this disease, we report a case of Group II NSIP which developed during treatment with corticosteroid 4 months after acute respiratory distress syndrome (ARDS). This case suggests that any group of NSIP may be developed after ARDS, and that low‐dose corticosteroid treatment is not sufficient to prevent the development of NSIP.